Find a TenderAwarded
Published 21 May 2026, 11:43 BST

Official UK procurement notice

Seasonal Influenza Vaccines 2026/2027

Official notice

Authority: Regional Business Services Organisation Procurement and Logistics Service

GoodsRestricted procedure
Awarded value£5,037,766published contract · exc. VAT
Awarded 13 Apr 2026
Awarded to Seqirus UK Ltd

What is being bought

Published requirement description

This contract is for the procurement of Seasonal Influenza Vaccines for the population of Northern Ireland

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published
Lot #1Contract 6100211 is established under the Medicinal Products Dynamic Purchasing System…Awarded

Contract 6100211 is established under the Medicinal Products Dynamic Purchasing System (131864). This contract is for Seasonal Influenza vaccines for the population of Northern Ireland.

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
Quality: 80Price: 40
Published sub-criteria (10)
  • All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 2-6): 10
  • Categories A & B only: Governance, Quality Control and Risk (Safety Engineered Protective Needle): 10
  • Categories C & D only: Governance, Quality Control and Risk (Safety Engineered Protective Needle): 4
  • Categories A & B only: Product Makeup (Ovalbumin Content): 10
  • All Categories (A, B, C, D): Product Makeup (Formaldehyde Content): 1
  • All Categories (A, B, C, D): Product Makeup (Latex Status/Threat): 1
  • All Categories (A, B, C, D): Supporting Information (Availability of PILs): 3
  • All Categories (A, B, C, D): Supply and Delivery of Product (Delivery Timescales): 25
  • Categories C & D only: Product Licence (Age Group Coverage): 16
  • Price: 40
Published award criteria (14)
  • All Categories (A, B, C, D): Compliance with Contract Scope and Specification / Weighting:: Pass/Fail
  • All Categories (A, B, C, D): Registration on the NHS Evergreen Sustainable Supplier Assessment platform: Pass/Fail
  • All Categories (A, B, C, D): Supply and Delivery of Product (GDP Compliance): Pass/Fail
  • All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 1): Pass/Fail
  • All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 2-6): 10%
  • Categories A & B only: Governance, Quality Control and Risk (Safety Engineered Protective Needle): 10%
  • Categories C & D only: Governance, Quality Control and Risk (Safety Engineered Protective Needle): 4%
  • Categories A & B only: Product Makeup (Ovalbumin Content): 10%
  • All Categories (A, B, C, D): Product Makeup (Formaldehyde Content): 1%
  • All Categories (A, B, C, D): Product Makeup (Latex Status/Threat): 1%
  • All Categories (A, B, C, D): Supporting Information (Availability of PILs): 3%
  • All Categories (A, B, C, D): Supply and Delivery of Product (Delivery Timescales): 25%
  • Categories C & D only: Product Licence (Age Group Coverage): 16%
  • Price: 40%
What this means for your bid
  • Price carries 40 of 120 points: a 10% discount moves about 4 points. The method statement decides this lot, not the discount.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Restricted procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
21 May 2026, 11:43 BST
Last source update
21 May 2026, 11:43 BST
Authority reference
6100211
FTS notice number
2026/S 000-046961
Classification (CPV)
Pharmaceutical products
Delivery area
Northern Ireland (UKN)
Official registry OCID
ocds-h6vhtk-069edd Find a Tender

Publisher note: The figure in V.2.4 is the awarded figure based on volume of doses agreed at the time of tender award. However, should there be a requirement for additional volumes, the Authority reserves the right to purchase further volumes up to a combined overall maximum value of £6528000 which accounts for the tendered cost associated with the maximum volume of doses set out in the tender documentation. Should additional product be required under this contract, the maximum value of combined purchases shall not exceed £6528000.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £5,037,7661 contract exc. VAT
Bids received 2
Contracts signed 1latest 13 Apr 2026
Awarded toValueDateStatus
Seqirus UK Ltd£5,037,766 †—Awarded

Contracts

  • Seasonal Influenza Vaccines 2026/2027 · Seqirus UK Ltd

    Signed
    13 Apr 2026
    Value
    £5,037,766
    Status
    active

Bid statistics published by the authority

BidsSMEVCSEValid bid range
2bids———

Contracting authority & participating public bodies

Regional Business Services Organisation, Procurement and Logistics Service

Contracting authorityBody governed by public lawHealth 77 Boucher Crescent, Belfast, Northern Ireland, BT126HUContact email

Dispute resolution & review bodies

  • Business Services Organisation, PaLSReview body BelfastContact email

Bidders & participating suppliers

1 commercial party on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.